Panbela Therapeutics logo
  • About Us
    • Company Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Our Science
    • Overview of SBP-101
    • Science
    • Pipeline
    • Clinical Trials
    • Expanded Access Policy
  • Newsroom
    • Press Releases
    • Events & Presentations
  • Investor Relations
    • Corporate Governance
    • Financial Information
    • Annual Reports & Proxy Statements
    • Investor Contact Info
  • Contact

Financial Information

  • Overview
  • Corporate Governance
  • Financial Information
  • Annual Reports & Proxy Statements
  • Investor Contact Information
SEC and XBRL Filings »

Quick Links

  • Home
  • About Us
  • Our Science
  • Newsroom
  • Investor Relations
  • Contact

Contact

bd@panbela.com
 
Sign up to receive press releases via email:

News & Events

Panbela Set to Join Russell Microcap® Index

Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting

Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors

Copyright ©2021 Panbela Therapeutics, Inc. All Rights Reserved.